-
Share
1,161 Posts.
859
18/07/21
12:08
Share
Agree, Dr Priscilla Brastianos has always championed Paxalisib (GDC-0084) for her preference in the PI3K arm of the ALLIANCE trial.
It is a closed shop as for any trial information leaking out of her Lab.
IMO the analysts have not valued the progress of this study, Huge potential for a Kazia share re-rating on the release of positive news.
Regards.
-